| Atypical Chronic Myeloid Leukemia studied in …STUDIED_INderived39 of 39show fewer |
|---|
| → studied in | NCT06523556Phase 1/Phase 2 · recruiting Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862157Phase 1/Phase 2 · active not recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03289910Phase 2 · active not recruiting Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05549661Phase 1 · recruiting Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms · condition mapped CURATED_BROADER · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03964506early Phase 1 · recruiting Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07468916Phase 2 · not yet recruiting Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04761770Phase 2 · active not recruiting Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07238712Phase 2 · recruiting Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00489203Phase 2 · completed Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02092324Phase 2 · completed Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397813Phase 2 · completed Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00856388NA · completed Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00105001Phase 2 · completed Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01159067Phase 2 · terminated Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039091Phase 1 · terminated Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898079completed Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01484015Phase 1 · completed Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02210858Phase 1/Phase 2 · completed Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076270NA · terminated Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118352Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795769Phase 2 · completed Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02564536Phase 1 · withdrawn Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408681NA · completed Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00509249Phase 2 · terminated Aflibercept in Treating Patients With Myelodysplastic Syndromes · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381550Phase 2 · completed 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00351975Phase 1 · completed Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387426Phase 2 · terminated Sunitinib in Treating Patients With Idiopathic Myelofibrosis · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231919Phase 1 · completed MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01233921NA · completed Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049582Phase 1 · terminated Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357305Phase 1 · completed Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060372Phase 1 · completed Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025415Phase 1 · completed Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01558778NA · withdrawn Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00799461Phase 3 · completed Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications · condition mapped ONTOLOGY_EXACT · 39 trials mapped (9 active) | — | — | Atypical Chronic Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |